B019 Injection

· Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for B019 Injection, covering 2025-05-22 to 2025-11-20. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma. [Phase 1]

See pricing